If you work, you can make more money.

Ya I thought about that, this was just a peak.

Yes sir they are.
I think we will have third party press from this data and turn some heads.
But we shall see

"If the spread is any indicator of what ELTP will do today"

No its not, a 10-20% spread is not uncommon pre market. So don't worry your 800k shares below a dime, they will do just fine today.

Good morning sun shine!

So what were thoughts on the data from the human liability studies?
Seems like the science works really really well.

GLTA Longs

I love it.
We have gone from "Elite has made no progress on their ADT/ART tech in 7 years" to they are just moving 7 forward not 17.

What will the argument be this time next year? lol

THey Only have 2 or three of their ADT/ART products on the market not 6?

ELITE has never looked better.

I agree with the whole post.

ib

Daily fluctuations, stocks tend to do that.

In your opinion what would make it clinically significant? Larger study? Why is that important for it to be clinically sig if the FDA uses the results for labeling and excepts them as is ?

BTW I really appreciate getting an answer to the previous question.

So do you think the data from the human liability test is statistically significant?
If not, why not?

Care to comment on the science behind the human liability data and results?


rdragon Wednesday, 09/10/14 09:59:26 AM
Re: richme post# 126083
Post # of 126105
Care to comment on the science behind the human liability data?
Impressive huh.
The market may not respond right away, but it will.

GLTA Longs

Care to comment on the science behind the human liability data?
Impressive huh.
The market may not respond right away, but it will.

GLTA Longs

But your not, 800k shares below a dime. I can dig the post back up if you would like.

Not what I remember.

GLTU

Just be glad you got in before the main stream press.

Look at the opportunity we have, Pretty Unbelievable!!!

I think the press will come between now and the time we file. I remember NH saying he would hit the road once he had more and conclusive data. It coming in pretty fast now.

GLTU

Gone pretty much the whole day yesterday, wow human liability data looks very very good.

GLTA Longs

"Pump & Dump part II,"

You might want to check out the chart. Do P&D keep and consolidate at 3-400 percent gains?

If this is part two than we should run up to ,oh around 2.70 and then settle back down to about 1.20 for our next base. Then comes P&D number 3, and 5 all the way until Elite is bought out.

GLTA Longs

" NH's 2014 is totally different than ELTP JT/NH's 2013.'

Night and day. my friend.

GLTA Longs

I don't expect an immediate response to the Investors conference presentation. What I do think is we will see a slow but steady volume and price increase following the meeting.

Until we get one of the many expected pr's this fall.

GLTA Longs

Bet we close green, but it really does not matter, I am looking at the big pic.

Count me in!!!, I am " one of the may still with the though"

Really think Elite will begin to get more 3rd party press over the coming 12 weeks.
We are still way under the radar with a break through product in a several billion dollar market.

GLTA Longs

I am also very interested, what part of the company is a scam?

Thank you for your service.

“if a product is designed and engineered in a way that most will not buy it; what good is it”?

Let me try with a little simpler wording. In what way is the methodology designed and engineered in a way that will not work.

Because it is, is an answer I hear from 3rd graders.

Yes sir you are, when other were yelling .04, you were saying buy hold and accumulate. Very glad I listened.

Facts are still facts no matter how many times folks say there not.

THink we are about ready to move again, this time to a higher high and then some tanksoildation to a new higher base.

GLTU

I will find out and let you know, you answer the question.

So why does the Elite continue to put money into further tests, like the very expensive human liability studies if results of the BE trials were not excellent. Does NH want to drive the price of his shares down? LOL

About 10-12 weeks before Elite files at least one NDA for their superior ART/ADT.

I think ELTP is about ready to explode.I picked up a few more shares this afternoon.

To think I could still buy them for less than 50 cents with the first ARt/ADT NDA just a few short months away. I believe, in the next 10-12 weeks those that have doubted will finally understand why NH has put so much of his own money on the line. Why he bought 11 million shares on the open market, loaned the company 1 million dollars in exchange for shares and takes shares not cash in compensation.

GLTA Longs

I think your 6.00 dollar target will come to pass around the time Elite's second art/adt is hitting the shelves.

GLTA Longs

Pretty typical for a be study.

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Third Opioid Abuse Deterrent Product
Print
Alert
Elite Pharmaceuticals, Inc. (QB) (OTCBB:ELTP)
Historical Stock Chart
6 Months : From Mar 2014 to Sep 2014

Click Here for more Elite Pharmaceuticals, Inc. (QB) Charts.

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pivotal bioequivalence study in healthy volunteers for ELI-202, an undisclosed opioid abuse deterrent product, utilizing Elite's proprietary pharmacological abuse deterrent technology.
Two bioequivalence studies will be run together for ELI-202. The first study is a single-dose, open-label, three treatment, three-way crossover study in which 32 healthy adult subjects will receive treatment in a partially randomized sequence. The primary objective of this first study is to compare the bioavailability of the Company's abuse deterrent product to that from the reference listed drug under fasted conditions. The secondary objectives are to compare the bioavailability of the Company's abuse deterrent product under fasted and fed conditions, and to evaluate the safety and tolerability of the Company's product. The second study is a single-dose, open-label, two treatment, two-way crossover study in which 32 healthy adult subjects will receive randomized treatment. The primary objective of this second study is to compare the bioavailability of the Company's abuse deterrent product to that of the reference listed drug under fasted conditions and the secondary objective is to evaluate the safety and tolerability of the Company's product.

Standard procedure, contact the FDA. Stops them from getting pressure.

Why is company continuing to spend money on more trials ,like the human liability trials if the results were not good?

Things that make you go hmmm.

You really believe that and your entire net worth is in ELTP?
I would sell.

I would not be surprised to see ELTP close green on pretty nice volume today.
Who knows, it just an inter day blip!!!!

GLTA Longs

Lots of stuff going on when we sat below a dime. I remember hearing this would never hold above a dime. It was all doom and gloom, now we are dooming and glooming above .30.


GLTA Longs

Trying to pick up a few shares today?
Wow super positive or it is never going to happen.
.We are on schedule to sit down with FDA in about 6 weeks. Relax.


GLTA Longs

Waiting for Elite to file for their first ART NDA only a few months away.
I'll bet you are looking forward to it also after accumulating 100s of Ks below a dime.

FWIW which appears to be some nice volume.

$heff Member Level Tuesday, 09/02/14 01:38:03 PM
Re: $heff post# 75489
Post # of 82917
Important Update regarding lotto plays as of 9/1/14: As may know I only select a few OTCBB each year to be allowed on my board. It's usually no more than four. They are only biotech because this is predominately a bio/pharma board. These stocks are selected because they have been recommended as potential solid trades by many readers on this board here via private messages. These IMO are the ones with greatest potential price appreciation in the next 6-9 months. They are just a handful of picks & all of them are risky. They also have good management & a few have institutional interest. Other than these few OTCBB stocks this is a BIG BOARD & BIOTECH STOCK THREAD. These specific biotech stocks have pending catalysts or PDUFA dates near-term: those stocks for remainder of 2014 & into 2015 are:

Allowed on my thread are these 4: $SNGX (fully reporting OTCBB), $CTSO (fully reporting OTCBB) , $ELTP (fully reporting OTCBB), $TTNP (fully reporting OTCBB).

"But Elite is just not any other company. It has game changers, it has patents, it has world class company officers, it has 17 opioid dream, a pipe that doesn't end, Big Pharma loves it, and FDA has regular meetings with it"

Great post, so much going for Elite.

I can only hope you are right I want to buy more at eow.
Keep up the good work.

"I sAw this big pic a while ago . '

hey me to thats why I loaded up when others were saying .04.

Elite's art/adt is coming to a pharmacy near you.